# FDA Inspection 707931 - Biomat USA, Inc. - February 02, 2011

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/09a46dc5-2e99-4626-bccf-76dcd8380631
Source feed: FDA_Inspections

> FDA Inspection 707931 for Biomat USA, Inc. on February 02, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 707931
- Company Name: Biomat USA, Inc.
- Inspection Date: 2011-02-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1122680 - 2020-02-26](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2fc5bec5-340d-4238-8184-6caacf512924)
- [FDA Inspection 1057025 - 2018-06-01](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6a7a7431-9b34-42bc-b02c-0586b8dab9e0)
- [FDA Inspection 964006 - 2016-01-25](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6084f572-cb37-44a5-b45d-aca46c3b4370)
- [FDA Inspection 820128 - 2013-02-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7797c3b0-1009-4815-9184-188c71f36994)
- [FDA Inspection 615024 - 2009-09-30](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e7826534-30dd-4a8f-af28-ea60e18a422e)

Company: https://www.keypedia.com/companies/biomat-usa-inc/6dabe0dd-ef1d-4700-92b8-35e723965973

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d